Skip to main content
. 2023 Jan 23;10:1091634. doi: 10.3389/fmed.2023.1091634

TABLE 3.

Association between BIH (Bevacizumab-Induced Hypertension) and first-line bevacizumab-based chemotherapy.

BIH
No (%) Yes (%) P
Disease control
No 22 (33.8) 2 (5.7)
Yes 43 (66.2) 33 (94.3) 0.0018